S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
BioNexus Gene Lab Corporation (BGLC)
BioNexus Gene Lab Corporation (BGLC) Financials

BGLC BioNexus Gene Lab Corporation

0.445

0.003 (0.68%)

Jun 17 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	21.631	7.639	-3.888	-26.107
Return on Equity (%)	32.843	10.865	-5.143	-32.212
Return on Invested Capital (%)	34.512	12.291	-5.697	-39.103
Operating Margin (%)	11.176	7.902	-2.663	-26.538
Net Profit Margin (%)	9.605	5.627	-3.257	-26.906
Book Value Per Share	0.065	0.042	0.038	0.547
Earnings Per Share	0.011	0.004	-0.002	-0.149
Cash Per Share	0.007	0.003	0.004	0.149
Working Capital Per Share	0.045	0.028	0.023	0.363
Operating Profit Per Share	0.026	0.014	0.009	0.107
EBIT Per Share	0.012	0.006	-0.002	-0.148
EBITDA Per Share	0.012	0.006	-0.002	-0.148
Free Cash Flow Per Share	0.014	0.004	-0.002	-0.145

Liquidity Ratios

Year End December 30 2023	2020	2021	2022	2023
Current Ratio	2.367	3.071	3.005	4.934
Quick Ratio	1.392	1.691	1.737	2.099
Inventory Turnover (Days)	37.686	41.572	32.663	42.51
Shares Outstanding	N/A	N/A	173.72M	17.67M

Key Stats and Ratios

Year End December 30 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	171.22M	171.22M	173.72M	173.72M	173.72M	173.72M	N/A	17.67M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	1.155	N/A	N/A	N/A	-2.146	N/A	N/A	N/A
Net Profit Margin (%)	0.561	N/A	N/A	N/A	-2.903	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	3.327	N/A	N/A	N/A	3.493	N/A	N/A	N/A
Quick Ratio	1.835	N/A	N/A	N/A	1.878	N/A	N/A	N/A
Inventory Turnover (Days)	198.707	N/A	N/A	N/A	138.199	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	7.95M
Price to Earnings Ratio	-3.02
Price to Sales Ratio	0.78
Price to Cash Ratio	3.03
Price to Book Ratio	0.82
Dividend Yield	-

Share Statistics

Shares Outstanding	17.67M
Average Volume (1 week)	89.79k
Average Volume (1 Month)	344.8k
52 Week Change	-87.29%
52 Week High	9.49
52 Week Low	0.31

More Ratios Coming Soon!

BioNexus Gene Lab

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions